Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam D Sanderson

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Vaccine|October 20, 2009
Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine designEdward L Morgan, Brandon N Morgan, Elisabeth A Stein, et al.
Journal of Neurochemistry|February 6, 2010
Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's diseaseRahasson R Ager, Maria I Fonseca, Shu-Hui Chu, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2013
A novel C5a-derived immunobiotic peptide reduces Streptococcus agalactiae colonization through targeted bacterial killingCourtney K Cavaco, Kathryn A Patras, Jaime E Zlamal, et al.
International Immunopharmacology|January 23, 2003
Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvantSam D Sanderson, Srinivasa R Cheruku, Maniyan P Padmanilayam, et al.
Plos Pathogens|December 25, 2013
Novel strategies to enhance vaccine immunity against coccidioidomycosisGarry T Cole, Chiung-Yu Hung, Sam D Sanderson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2009
Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's diseaseMaria I Fonseca, Rahasson R Ager, Shu-Hui Chu, et al.
International Journal of Pharmaceutics|May 12, 2019
Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infectionShailendra B Tallapaka, Bala V K Karuturi, Pravin Yeapuri, et al.
The Journal of Biological Chemistry|December 31, 2002
The amyloid precursor-like protein 2 and the adenoviral E3/19K protein both bind to a conformational site on H-2Kd and regulate H-2Kd expressionChantey R Morris, Jason L Petersen, Shanna E Vargas, et al.
ACS Infectious Diseases|April 3, 2020
Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67Abdulraman M Alshammari, D David Smith, Jake Parriott, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Vaccine|October 20, 2009
Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine designEdward L Morgan, Brandon N Morgan, Elisabeth A Stein, et al.
Journal of Neurochemistry|February 6, 2010
Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's diseaseRahasson R Ager, Maria I Fonseca, Shu-Hui Chu, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2013
A novel C5a-derived immunobiotic peptide reduces Streptococcus agalactiae colonization through targeted bacterial killingCourtney K Cavaco, Kathryn A Patras, Jaime E Zlamal, et al.
International Immunopharmacology|January 23, 2003
Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvantSam D Sanderson, Srinivasa R Cheruku, Maniyan P Padmanilayam, et al.
Plos Pathogens|December 25, 2013
Novel strategies to enhance vaccine immunity against coccidioidomycosisGarry T Cole, Chiung-Yu Hung, Sam D Sanderson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2009
Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's diseaseMaria I Fonseca, Rahasson R Ager, Shu-Hui Chu, et al.
International Journal of Pharmaceutics|May 12, 2019
Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infectionShailendra B Tallapaka, Bala V K Karuturi, Pravin Yeapuri, et al.
The Journal of Biological Chemistry|December 31, 2002
The amyloid precursor-like protein 2 and the adenoviral E3/19K protein both bind to a conformational site on H-2Kd and regulate H-2Kd expressionChantey R Morris, Jason L Petersen, Shanna E Vargas, et al.
ACS Infectious Diseases|April 3, 2020
Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67Abdulraman M Alshammari, D David Smith, Jake Parriott, et al.
Pageof 3